SIRT1 and acute kidney injury: Despite these limitations, the identification of a temporal decline in SIRT1 levels among CI-AKI patients provides a valuable signal and supports the need for further research evaluating SIRT1 as a component of dynamic biomarker panels for acute kidney injury.